Patents Assigned to ELSALYS BIOTECH
  • Compounds binding human CD160 and uses thereof
    Patent number: 10975159
    Abstract: Novel compounds which bind specifically to human CD160, including a light chain variable domain (VL), a chosen sequence defined by SEQ ID No: 14 or SEQ ID No: 13 and a heavy chain variable domain (VH), a sequence chosen from SEQ ID No: 11, SEQ ID No: 25, SEQ ID No: 26, SEQ ID No: 27, SEQ ID No: 28, SEQ ID No: 29 or SEQ ID No: 30, fragments thereof or derivatives thereof.
    Type: Grant
    Filed: January 8, 2018
    Date of Patent: April 13, 2021
    Assignee: ELSALYS BIOTECH
    Inventors: Alexandre Calcei, Hélène Haegel, Thierry Menguy, Caroline Rozan
  • COMPOUNDS BINDING HUMAN CD160 AND USES THEREOF
    Publication number: 20200109211
    Abstract: Novel compounds which bind specifically to human CD160, including a light chain variable domain (VL), a chosen sequence defined by SEQ ID No: 14 or SEQ ID No: 13 and a heavy chain variable domain (VH), a sequence chosen from SEQ ID No: 11, SEQ ID No: 25, SEQ ID No: 26, SEQ ID No: 27, SEQ ID No: 28, SEQ ID No: 29 or SEQ ID No: 30, fragments thereof or derivatives thereof.
    Type: Application
    Filed: January 8, 2018
    Publication date: April 9, 2020
    Applicant: ELSALYS BIOTECH
    Inventors: Alexandre CALCEI, Hélène HAEGEL, Thierry MENGUY, Caroline ROZAN